Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

SOLUGEN INC

Filed by SOLUGEN INC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
Not reported
Expenses
$120,000.00
Registrant
SOLUGEN INC
Filing UUID
3d62debf-8864-42af-a83a-0d538f3c6137
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

DEF · Defense

Support the use of bio-based chemicals in the Department of Defense, generally. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

ENV · Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-182) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.